Effect of Daunomycin and its new analog, Adriamycin, on nucleic acid biosynthesis was compared in L-1210 leukemia cells and in human leukemic leucocytes
in vitro by the use of labeled adenine incorporation. Daunomycin was demonstrated to be significantly more effective than Adriamycin in inhibiting RNA and DNA synthesis in leukemic cells at the same concentration studied. On the other hand, the reaction catalysed
in vitro by DNA polymerase activity in 100, 000
g supernatant prepared from L-1210 leukemia cells was quite equally inhibited in the presence of Daunomycin and Adriamycin, suggesting their same effect on template activity of primer DNA. In fact, interaction of both antibiotics with calf thymus DNA
in vitro, which was determined by using Sephadex G-25 column chromatography, showed no appreciable difference between Daunomycin and Adriamycin in binding affiinity to calf thymus DNA.
Studies on cell-drug interaction, however, revealed that the uptake of Daunomycin by leukemia cells was considerably greater than that of Adriamycin. Both Daunomycin and Adriamycin were judged rather stable in leukemic cells and in the medium during incubation from the analysis of metabolites using a thin-layer chromatography, indicating that neither activation nor inactivation plays any rôle in the different effects of these antibiotics.
Since the essential mechanism of action of both antibiotics, such as binding to DNA and inhibiton of DNA polymerase reaction, was found to be quantitatively similar in the cell-free system, better accessibility of Daunomycin to DNA in leukemic cells due to the greater cellular uptake may account for the superiority of Daunomycin to Adriamycin in inhibiting the nucleic acid metabolism in leukemia cells
in vitro.
View full abstract